GlassScriptPhysician profile
Amr Essa
NPI 1174057699
$4,518.17
in general payments reported to CMS, 2019-2025
17 companies · $85.91 in 2025
The $85.91 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $399 · 2022: $2,888 · 2023: $285 · 2024: $860 · 2025: $85.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,826.92 | 2021-2023 | Mitraclip |
| Medtronic, INC. | $654.79 | 2022-2024 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Linq II |
| Cvrx, INC. | $285.84 | 2024 | Barostim Neo System |
| Abiomed | $243.97 | 2022-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $125.62 | 2023-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $99.95 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.38 | 2022 | |
| Inari Medical, INC. | $42.66 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Acist Medical Systems, INC. | $24.18 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $21.40 | 2023 | Arcalyst |
| Amgen INC. | $20.61 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $16.41 | 2023 | Inpefa |
| Pfizer INC. | $16.26 | 2021 | |
| Cleerly, INC. | $13.78 | 2023 | Cleerly Labs |
| W. L. Gore & Associates, INC. | $13.58 | 2024 | Gore Cardioform Septal Occluder |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $13.53 | 2021 | |
| Asahi Intecc USA, INC. | $13.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amr Essa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.